Skip to main content

Government Employees Hospital Ass'n v. Serono International, S.A.

D. Mass.November 7, 2007No. Civil Action Nos. 05-11935-PBS, 06-10613-PBS
SettlementSerono Laboratories, Inc.$24,000,000 awarded
Facing something similar at work?Check your rights — free, private, no sign-up

Case Details

Judge(s)
Saris
Status — whether other courts must follow this ruling
Published
Procedural Posture — the stage the case had reached
consent decree

Related Laws

No specific laws identified for this ruling.

Outcome

Court approved class certification and settlement of $24 million involving fraudulent promotion of pharmaceutical drug Serostim. Court deferred final determination on attorneys' fees, expenses, and reimbursement pending further submissions due to concerns about fair-share contribution by separately settling Health Plans.

What This Ruling Means

**Hospital Workers Win $24 Million Settlement Over Drug Company Fraud** This case involved employees at Government Employees Hospital Association who sued pharmaceutical company Serono International for fraudulent marketing practices. The workers alleged that Serono illegally promoted its drug Serostim, which violated consumer protection laws and constituted fraud. The employees claimed this deceptive marketing harmed their health plan and increased their healthcare costs. The court approved a class action settlement where Serono agreed to pay $24 million to resolve the fraud claims. The judge certified the case as a class action, meaning it could proceed on behalf of all affected hospital employees, not just individual workers. However, the court delayed finalizing attorney fees and expenses because of concerns about ensuring fair contributions from other health plans that settled separately. **What this means for workers:** This case shows that employees can successfully band together to challenge companies that engage in fraudulent practices affecting their health benefits. When employers or insurance companies are harmed by corporate fraud, workers who pay into those health plans may be able to recover damages through class action lawsuits. It demonstrates that courts will hold pharmaceutical companies accountable for illegal marketing that ultimately increases healthcare costs for working people.

This summary was generated to explain the ruling in plain English and is not legal advice.

Browse Related

Facing something similar at work?

Court rulings like this one are useful, but every situation is different. Take 2 minutes to see which laws may protect you — it's free, private, and no account is required to start.

This ruling information is sourced from public court records via CourtListener.com. Case outcomes, claim types, and summaries are extracted using AI analysis and may be incomplete or inaccurate. It is provided for informational and educational purposes only and does not constitute legal advice.

See something wrong, or named in this ruling and want it corrected or redacted? Request a correction.